Purple Mountain Investment Advisors LLC

Purple Mountain provides ongoing portfolio management and financial planning services to individual and high‑net‑worth clients, creating an Investment Policy Statement for each client to document goals, risk tolerance, and time horizon. The firm also operates a paid subscription newsletter that delivers specific buy and sell recommendations alongside its discretionary portfolio management services.

The firm’s investment approach combines multiple analysis methods — including charting, fundamental, technical, cyclical and quantitative analysis, and modern portfolio theory — and it employs both long‑term and short‑term trading with discretionary authority. Purple Mountain commonly concentrates recommendations in the pharmaceutical and biotech sectors and explicitly discusses the heightened, security‑specific risks of those industries and the need for close monitoring and prudent allocation.

Noteworthy aspects disclosed in the brochure include the subscription newsletter that issues security‑level advice, an arrangement relatively uncommon among peers, and the firm’s in‑house management model that does not rely on third‑party advisers. The brochure also discloses an affiliated consulting business that provides services to pharma/biotech companies (including large global firms), a relationship the firm identifies and addresses in its disclosures and policies.